Research Participant Registry "Hopkins Opportunities for Participant Engagement" (HOPE Registry)

November 3, 2026 updated by: Johns Hopkins University

"HOPE" Research Participant Registry "Hopkins Opportunities for Participant Engagement"

The HOPE (Hopkins Opportunities for Participant Engagement) Research Registry is a free and secure way for adults to learn about research studies at Johns Hopkins and find out about opportunities to participate. HOPE was created to help connect people who are interested in research with Johns Hopkins research teams conducting studies in many different health areas.

Adults age 18 or older who live in the United States may voluntarily join HOPE. To enroll, participants complete a short form that takes about 5 minutes and provide basic information about themselves and the types of research the participant may be interested in. Participants may receive information about new research studies, including studies related to the topics selected.

If a participant is interested in a study, the participant can choose to share contact information with the research team so the team can contact the participant directly. Joining HOPE does not mean that a person has to participate in any research study. Participation in HOPE is voluntary, there is no cost to join, and participants can update information or leave the registry at any time.

Study Overview

Status

Not yet recruiting

Intervention / Treatment

Detailed Description

The HOPE (Hopkins Opportunities for Participant Engagement) Research Registry is a free, secure, disease-agnostic research recruitment registry designed to connect adults who are interested in research with research opportunities at Johns Hopkins University. The registry was established to provide a centralized resource where individuals can learn about Johns Hopkins research studies and, if interested, choose to be contacted by research teams.

HOPE is a dynamic registry, meaning that individuals may join on an ongoing basis and may update information or remove themselves from the registry at any time. The registry is intended to support recruitment for Johns Hopkins research studies that have appropriate Institutional Review Board (IRB) approval. HOPE is not itself a research study requiring participants to participate in a specific research intervention or procedure.

Participant information is securely stored and managed within the Johns Hopkins REDCap system. Access to identifiable information is limited to authorized personnel who are approved on the relevant IRB protocols and have completed required privacy training. Study teams using HOPE for recruitment receive limited access to information necessary to contact individuals who have expressed interest in the specific study.

The primary risk associated with joining HOPE is a potential loss of confidentiality of the personal information provided to the registry. Measures are in place to reduce this risk, including secure data storage, controlled access, required privacy training, and routine review of data access and security. There are no medical risks associated with participating in the registry.

Study Type

Observational

Enrollment (Estimated)

1000

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Foujan Moghimi, MSPH
  • Phone Number: 667-306-9348
  • Email: fmoghim2@jh.edu

Study Locations

    • Maryland
      • Baltimore, Maryland, United States, 21202
        • Johns Hopkins ICTR SOM
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

The study population consists of adults age 18 or older who reside in the United States and are interested in learning about research opportunities and/or receiving information about research studies at Johns Hopkins. Participants may include Johns Hopkins patients as well as members of the general community.

Description

Inclusion Criteria:

  • Age 18 years or older
  • Resides in the United States
  • Apple to provide informed consent
  • Interested in learning about research opportunities and/or receiving research updates
  • Able to read English

Exclusion Criteria:

  • Under 18 years of age
  • Unable to provide informed consent
  • Resides outside of the United States

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: OTHER
  • Time Perspectives: OTHER

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of individuals enrolled in the HOPE Research Registry
Time Frame: Ongoing throughout the duration of the registry, 5 years

The number of individuals who voluntarily enroll in the HOPE Research Registry after completing the required consent process. Enrollment will be monitored as an ongoing measure of the reach and use of the registry.

Ongoing throughout the duration of the registry, 5 years

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of registry participants who share contact information with a research team
Time Frame: Ongoing throughout the duration of the registry, 5 years

The number of HOPE participants who explicitly indicate interest in an IRB-approved research study and choose to share demographic and contact information with the study research team. This measure will be used to evaluate participant engagement with research opportunities provided through HOPE.

Ongoing throughout the duration of the registry, 5 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Daniel Ford, MD, Johns Hopkins University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

January 1, 2027

Primary Completion (Estimated)

December 31, 2028

Study Completion (Estimated)

December 31, 2029

Study Registration Dates

First Submitted

November 3, 2026

First Submitted That Met QC Criteria

November 3, 2026

First Posted (Actual)

November 9, 2026

Study Record Updates

Last Update Posted (Actual)

November 9, 2026

Last Update Submitted That Met QC Criteria

November 3, 2026

Last Verified

November 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

Individual participant data (IPD) collected through the HOPE Research Registry will not be routinely shared with external researchers. HOPE participants' demographic, contact, and research-interest information will only be shared with a Johns Hopkins research team when the participant explicitly indicates interest in a specific IRB-approved study and chooses to share their information with that research team. Shared information may include the participant's name, contact information, race, gender, ethnicity, and other relevant registry information provided by the participant.

IPD Sharing Time Frame

Start Date: July 17, 2026 End Date: Ongoing IPD and supporting information will be available on an ongoing basis throughout the duration of the HOPE Research Registry. IPD will be shared with authorized Johns Hopkins research teams only when a participant explicitly indicates interest in an IRB-approved study and chooses to share their information.

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe